Keimyung University Reports Findings in Cancer (Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy)

    Press/Media: Research

    PeriodJul 5 2023

    Media coverage

    1

    Media coverage